Fibrillin 1
Showing 1 - 25 of >10,000
Towards Optimal Treatment of Marfan Syndrome
Recruiting
- Marfan Syndrome
- Magnetic Resonance imaging examination
-
Nijmegen, Gelderland, Netherlands
- +3 more
Jul 6, 2023
Photoaging of Skin, Skin Aging Trial (skin biopsy)
Not yet recruiting
- Photoaging of Skin
- Skin Aging
- skin biopsy
- (no location specified)
May 13, 2023
Marfan Syndrome and Facial Dysmorphism: Non-invasive 3D
Recruiting
- Rare Diseases
- Marfan Syndrome
-
San Donato Milanese, Lombardia, ItalyIRCCS Policlinico San Donato
Jan 27, 2023
Immunohistological and Biomechanical Properties of Thoracic
Recruiting
- Thoracic Aortic Aneurysm
-
Rotterdam, NetherlandsErasmus MC
Dec 6, 2022
Marfan Syndrome Trial in Paris (Endurance training, Muscle building training)
Completed
- Marfan Syndrome
- Endurance training
- Muscle building training
-
Paris, FranceGroupe Hospitalier Bichat - Claude Bernard
Sep 30, 2022
Visual Prognosis and Complications of Ectopia Lentis Lens
Recruiting
- Ectopia Lentis
- Dislocation, Lens
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Clinical Research Center for Ocular Disease
Dec 23, 2022
Chronic Effect of Ultraviolet Radiation on Photoaged Skin, Dermatologic Disorders Trial in La Mesa, San Diego (Allogeneic
Active, not recruiting
- Chronic Effect of Ultraviolet Radiation on Photoaged Skin
- Dermatologic Disorders
- Allogeneic Mesenchymal Bone Marrow Cells
-
La Mesa, California
- +1 more
Oct 27, 2022
Thoracic Aortic Dissection Trial in Ann Arbor, Saint Louis, Houston (Guided Exercise Training Program, Usual Care)
Not yet recruiting
- Thoracic Aortic Dissection
- Guided Exercise Training Program
- Usual Care
-
Ann Arbor, Michigan
- +2 more
Nov 4, 2022
Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal
Recruiting
- Renal Fibrosis, CKD
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 16, 2021
Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Rheumatoid Arthritis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)
Completed
- Ankylosing Spondylitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 10, 2023
COVID-19 Trial in Thái Bình (COVIVAC vaccine)
Completed
- COVID-19
- COVIVAC vaccine
-
Thái Bình, Thai Binh, VietnamDistrict Health Center of Vu Thu District
Jul 12, 2023
Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)
Not yet recruiting
- Relapsing Remitting Multiple Sclerosis
- PIPE-307 Dose A
- +2 more
- (no location specified)
Oct 9, 2023
Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of
Not yet recruiting
- Meningococcal Meningitis
- batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
- +3 more
-
Surabaya, IndonesiaHusada Utama Hospital
Nov 13, 2023
Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Atopic Dermatitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaJianzhong Zhang
Oct 10, 2023
Hypertension,Essential Trial in China (Songling Xuemaikang Capsules, Lifestyle intervention, Placebo)
Not yet recruiting
- Hypertension,Essential
- Songling Xuemaikang Capsules
- +2 more
-
Beijing, Beijing, China
- +4 more
Oct 17, 2023
Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)
Not yet recruiting
- Hepatocellular Carcinoma
- iNKT Cells
- +2 more
-
Beijing, Beijing, ChinaBeijing Youan Hospital,Capital Medical University
Jul 24, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 22, 2023
Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )
Recruiting
- Type1diabetes
- +2 more
- Infusion of GIP[1-42], GIP[1-30] or placebo
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 13, 2023
Diabetes Trial (INS062 injection?INS068 injection?HR20014 injection)
Not yet recruiting
- Diabetes
- INS062 injection、INS068 injection、HR20014 injection
- (no location specified)
May 24, 2023
Serum Retinoic Acid Induced Protein 14 and Metastasis Associated
Not yet recruiting
- Breast Cancer
- laboratory test (RAI14 and MACC-1 )
- (no location specified)
Oct 18, 2023
Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)
Recruiting
- Lymphoblastic Lymphoma
- +2 more
- BEAM-201
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 2, 2023
Tetanus Trial in Bijie (TTVA, TT)
Not yet recruiting
- Tetanus
- TTVA
- TT
-
Bijie, Guizhou, ChinaCenter for Disease Control and Prevention, Qixingguan District,
Nov 7, 2023